FX

Feng Xu

Merck: 3 patents #83 of 961Top 9%
NO Novozymes: 3 patents #12 of 60Top 20%
NA Novozymes A/S: 1 patents #94 of 264Top 40%
SC Shandong Danhong Pharmaceutical Co.: 1 patents #1 of 20Top 5%
Overall (2019): #18,986 of 560,194Top 4%
7
Patents 2019

Issued Patents 2019

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
10478412 GABA conjugates and methods of use thereof 2019-11-19
10472345 Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents Aaron M. Dumas, Jeremy Scott, Michael Shevlin, Zhijian Liu, John Y. L. Chung +1 more 2019-11-12
10435410 Process for making beta 3 agonists and intermediates John Y. L. Chung, Kevin R. Campos, Edward Cleator, Robert F. Dunn, Andrew Gibson +9 more 2019-10-08
10336993 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same Nikolaj Spodsberg, Tarana Shaghasi, Matt Sweeney, Kirk Matthew Schnorr 2019-07-02
10316343 Compositions comprising a polypeptide having cellulolytic enhancing activity and a liquor and uses thereof Jason Quinlan, Matt Sweeney, Don Higgins, Hui Xu 2019-06-11
10287289 Process for preparing beta 3 agonists and intermediates Zhuqing Liu, Richard Desmond, Jeonghan Park, Alexei Kalinin, Birgit Kosjek +3 more 2019-05-14
10227309 Crystal form A of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo [d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one Weihua Shi, Zheng Wang, Weidong Li, Linghui Wu, Hongwei Li +4 more 2019-03-12